References
1. Treviño González JL, Reyes Suárez LL, Hernández de León JE. Malignant otitis externa: An updated review. Vol. 42, American Journal of Otolaryngology - Head and Neck Medicine and Surgery. Am J Otolaryngol; 2021.
2. Hopkins ME, Bennett A, Henderson N, Macsween KF, Baring D, Sutherland R. A retrospective review and multi-specialty, evidence-based guideline for the management of necrotising otitis externa. Vol. 134, Journal of Laryngology and Otology. J Laryngol Otol; 2020. p. 487–92.
3. Mahdyoun P, Pulcini C, Gahide I, Raffaelli C, Savoldelli C, Castillo L, et al. Necrotizing otitis externa: A systematic review. Vol. 34, Otology and Neurotology. Otol Neurotol; 2013. p. 620–9.
4. Frost J, Samson A. Standardized treatment protocol for necrotizing otitis externa: retrospective case series and systematic literature review. J Glob Antimicrob Resist. 2021 Jul 14
5. Chandler JR. Malignant external otitis. Vol. 78, Laryngoscope. Laryngoscope; 1968. p. 1257–94.
6. Chawdhary G, Liow N, Democratis J, Whiteside O. Necrotising (malignant) otitis externa in the UK: A growing problem. Review of five cases and analysis of national Hospital Episode Statistics trends. J Laryngol Otol. 2015 Jun 16;129(6):600–3.
7. Hobson CE, Moy JD, Byers KE, Raz Y, Hirsch BE, Mccall AA. Malignant Otitis Externa: Evolving Pathogens and Implications for Diagnosis and Treatment. Otolaryngol Neck Surg. 2014;151(1):112–6.
8. Pankhania M, Bashyam A, Judd O, Jassar P. Antibiotic prescribing trends in necrotising otitis externa: A survey of 85 trusts in the United Kingdom: Our Experience. Vol. 41, Clinical Otolaryngology. Clin Otolaryngol; 2016. p. 293–6.
9. Chawdhary G, Pankhania M, Douglas S, Bottrill I. Current management of necrotising otitis externa in the UK: survey of 221 UK otolaryngologists. Acta Otolaryngol. 2017 Aug;137(8):818–22.
10. Singh J, Bhardwaj B. The Role of Surgical Debridement in Cases of Refractory Malignant Otitis Externa. Indian J Otolaryngol Head Neck Surg. 2018 Dec 1;70(4):549–54.
11. Peled C, Parra A, El-saied S, Kraus M, Kaplan DM. Surgery for necrotizing otitis externa—indications and surgical findings. Eur Arch Oto-Rhino-Laryngology. 2020 Feb 12;277(5):1327–34.
12. Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Diagnosis and Management: A Review. Vol. 322, JAMA - Journal of the American Medical Association. NIH Public Access; 2019. p. 1294–304.
13. Arsovic N, Radivojevic N, Jesic S, Babac S, Cvorovic L, Dudvarski Z. Malignant Otitis Externa: Causes for Various Treatment Responses. J Int Adv Otol. 2020 Apr 1;16(1):98.
14. Sylvester MJ, Sanghvi S, Patel VM, Eloy JA, Ying YLM. Malignant otitis externa hospitalizations: Analysis of patient characteristics. Laryngoscope. 2017 Oct 1;127(10):2328–36.
15. Austin SR, Wong YN, Uzzo RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the Charlson Comorbidity Index and Elixhauser score work. Med Care. 2015 ;53(9):e65–72.
16. Lullo AM Di, Russo C, Piroli P, Petti A, Capriglione P, Cantone E, et al. Malignant Otitis External: Our Experience and Literature Review. Am J Case Rep. 2020;21:e925060-1.
17. Hatch JL, Bauschard MJ, Nguyen SA, Lambert PR, Meyer TA, McRackan TR. Malignant Otitis Externa Outcomes: A Study of the University HealthSystem Consortium Database. Ann Otol Rhinol Laryngol. 2018 Aug 1;127(8):514–20.
18. Badaruddin A, Choo MM. Facial nerve palsy in otitis externa: A red flag? Malaysian Fam Physician Off J Acad Fam Physicians Malaysia. 2021 Feb 1;16(1):117.
19. Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med. 2017 Sep 1;177(9):1308–15.
20. Kokado R, Hagiya H, Koyama T, Matsui E, Okuno H, Morii D, et al. Antibiotic-associated adverse drug events at a Japanese academic hospital. J Infect Chemother. 2019 May;25(5):392–5.
21. Benli A, Şimşek-Yavuz S, Başaran S, Çağatay A, Özsüt H, Eraksoy H. Hematologic Adverse Effects of Prolonged Piperacillin-Tazobactam Use in Adults. Turkish J Hematol. 2018;35(4):290.
22. Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, et al. Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for pseudomonas aeruginosa bloodstream infection: A multisite retrospective study. Clin Infect Dis. 2020 May 23;70(11):2270–80.
23. Kim DH, Kim HS, Nam KH, Choi BK, Han IH. Adverse Drug Reactions of Long-term Intravenous Antibiotics in Patients with Pyogenic Spondylitis. Korean J Spine. 2014;11(3):113.
24. Hand K. Antibiotic stewardship. Vol. 13, Clinical Medicine, Journal of the Royal College of Physicians of London. Royal College of Physicians; 2013. p. 499–503.
25. Marina S, Goutham MK, Rajeshwary A, Vadisha B, Devika T. A retrospective review of 14 cases of malignant otitis externa. J Otol. 2019 Jun;14(2):63.